CH581640A5 - - Google Patents

Info

Publication number
CH581640A5
CH581640A5 CH1182373A CH1182373A CH581640A5 CH 581640 A5 CH581640 A5 CH 581640A5 CH 1182373 A CH1182373 A CH 1182373A CH 1182373 A CH1182373 A CH 1182373A CH 581640 A5 CH581640 A5 CH 581640A5
Authority
CH
Switzerland
Application number
CH1182373A
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP47082574A external-priority patent/JPS5238559B2/ja
Priority claimed from JP48039354A external-priority patent/JPS49125359A/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of CH581640A5 publication Critical patent/CH581640A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1182373A 1972-08-17 1973-08-16 CH581640A5 (en])

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP47082574A JPS5238559B2 (en]) 1972-08-17 1972-08-17
JP48039354A JPS49125359A (en]) 1973-04-05 1973-04-05
ZA00741280A ZA741280B (en) 1972-08-17 1974-02-26 Thiazole derivatives

Publications (1)

Publication Number Publication Date
CH581640A5 true CH581640A5 (en]) 1976-11-15

Family

ID=27290112

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1182373A CH581640A5 (en]) 1972-08-17 1973-08-16

Country Status (10)

Country Link
US (1) US3932400A (en])
CA (1) CA991640A (en])
CH (1) CH581640A5 (en])
DE (1) DE2341753C2 (en])
DK (1) DK149893C (en])
FR (1) FR2196162B1 (en])
GB (1) GB1435139A (en])
NL (1) NL179733C (en])
SE (1) SE421615B (en])
ZA (1) ZA741280B (en])

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001421A (en) * 1971-10-27 1977-01-04 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
US4119718A (en) * 1977-05-02 1978-10-10 Merck & Co., Inc. 3-Amino-2-oxy-propoxy-substituted isothiazoles
US4259341A (en) * 1977-06-01 1981-03-31 Merck & Co., Inc. Di- and tri-substituted thiazoles
US4260609A (en) * 1977-06-01 1981-04-07 Merck & Co., Inc. Di- and tri- substituted thiazoles
US4396625A (en) * 1980-05-13 1983-08-02 Sumitomo Chemical Company, Limited Treatment of glaucoma or ocular hypertension and ophthalmic composition
US4670450A (en) * 1985-11-13 1987-06-02 Merrell Dow Pharmaceuticals Inc. Cardiotonic thiazolones
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
GEP20084406B (en) * 2003-05-30 2008-06-25 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as hmg-co inhibitors
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
BRPI0518300A2 (pt) * 2004-11-23 2008-11-11 Warner Lambert Co derivados de Ácido 7-(2h-pirazol-3-il)-3,5-diidràxi-heptanàico como inibidores da hmg co-a reductase para o tratamento de lipidemia
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US20090226420A1 (en) * 2005-11-10 2009-09-10 Elizabeth Hauser Methods of Determining the Risk of Developing Coronary Artery Disease
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
BRPI0706621A2 (pt) * 2006-01-18 2011-04-05 Amgen Inc composto, composição farmacêutica, métodos para tratar um distúrbio mediado por quinase em um mamìfero e para tratar um distúrbio relacionado com a proliferação em um mamìfero, e , uso do composto
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
CN101494980A (zh) * 2006-07-14 2009-07-29 兰贝克赛实验室有限公司 HMG-CoA还原酶抑制剂的多晶型形式及其应用
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
AU2008276512A1 (en) * 2007-07-17 2009-01-22 Amgen Inc. Thiadiazole modulators of PKB
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN104530033B (zh) * 2014-12-26 2017-07-07 江西百神药业股份有限公司 一种盐酸阿罗洛尔的制备工艺新方法
CN105646472A (zh) * 2016-02-29 2016-06-08 山东齐都药业有限公司 一种盐酸阿罗洛尔的制备方法
JOP20210193A1 (ar) 2019-01-18 2023-01-30 Astrazeneca Ab مثبطات pcsk9 وطرق استخدامها

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA599475A (en) * 1960-06-07 W. Harman Marion Aminoethylthiazoles
US2221147A (en) * 1938-11-18 1940-11-12 Goodrich Co B F Preparation of aminated esters of sulphydryl compounds
US3228952A (en) * 1962-06-27 1966-01-11 Dow Chemical Co Thiazole thioethers
US3158623A (en) * 1963-03-01 1964-11-24 Abbott Lab 5-nitro-2-furylthioamide
BE790569A (fr) * 1971-10-27 1973-04-26 Syntex Corp Agents cardiovasculaires a base de thiazoles

Also Published As

Publication number Publication date
DE2341753A1 (de) 1974-02-21
FR2196162A1 (en]) 1974-03-15
NL179733B (nl) 1986-06-02
DE2341753C2 (de) 1982-12-09
ZA741280B (en) 1975-03-26
NL7311248A (en]) 1974-02-19
GB1435139A (en) 1976-05-12
NL179733C (nl) 1986-11-03
FR2196162B1 (en]) 1977-01-28
DK149893B (da) 1986-10-20
US3932400A (en) 1976-01-13
AU5928173A (en) 1975-02-20
SE421615B (sv) 1982-01-18
DK149893C (da) 1987-04-21
CA991640A (en) 1976-06-22

Similar Documents

Publication Publication Date Title
JPS5228645B2 (en])
CH564107A5 (en])
BG18940A1 (en])
BG21155A1 (en])
BG22072A3 (en])
CH1311472A4 (en])
CH284873A4 (en])
CH291173A4 (en])
CH51872A4 (en])
CH535672A4 (en])
CH559854A5 (en])
CH561445A5 (en])
CH562015A5 (en])
CH563886A5 (en])
CH564021A5 (en])
BG18297A1 (en])
CH564202A5 (en])
CH564956A5 (en])
CH565246A5 (en])
CH565301A5 (en])
CH565494A5 (en])
CH565749A5 (en])
CH565885A5 (en])
CH565895A5 (en])
CH565907A5 (en])

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased